Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Not applicable Interventional

Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study

ClinicalTrials.gov ID: NCT03901807

Public ClinicalTrials.gov record NCT03901807. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 2:45 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Multicenter, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of PMX Cartridge in Addition to Standard Medical Care for Patients With Endotoxemic Septic Shock

Study identification

NCT ID
NCT03901807
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
Spectral Diagnostics (US) Inc.
Industry
Enrollment
150 participants

Conditions and interventions

Interventions

  • Toraymyxin PMX 20R Extracorporeal Hemoperfusion Cartridge Device

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 8, 2020
Primary completion
May 7, 2025
Completion
Apr 29, 2026
Last update posted
Apr 2, 2026

2020 – 2026

United States locations

U.S. sites
20
U.S. states
16
U.S. cities
19
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294-0111
University of Arkansas for Medical Sciences Little Rock Arkansas 72205
University of California, San Francisco San Francisco California 94143
Pulmonary Associates Boulder Colorado 80909
George Washington University Washington D.C. District of Columbia 20037
Emory University Atlanta Georgia 30322
Louisiana State University Health Shreveport Shreveport Louisiana 71103
Baystate Medical Center Springfield Massachusetts 01199
University of Michigan Ann Arbor Michigan 48109
Mayo Clinic Rochester Minnesota 55905
Cooper Health System Camden New Jersey 08103
Rutgers, The State University of New Jersey Piscataway New Jersey 08854
Mt Sinai Hospital New York New York 10029
Stony Brook University Stony Brook New York 11794
UPMC Pittsburgh Pennsylvania 15213
Medical University of South Carolina Charleston South Carolina 29425
CHI Memorial Chattanooga Tennessee 37404
Parkridge Hospital Chattanooga Tennessee 37404
The University of Texas Health Science Center at Houston Houston Texas 77030
Institute for Extracorporeal Life Support San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03901807, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 2, 2026 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03901807 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →